Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Team Grant: Neuroinflammation

Université Laval

$104,235.00

Transition from acute to chronic neuroinflammation

FY 2014-15

Summary
Neuroinflammation is how the immune system of the brain fights against diseases. As a natural defense mechanism, this reaction may harbor beneficial effects, but under circumstances not yet well understood, it may also have detrimental consequences for the brain and even contribute to the progression of the disease that initially stimulated the immune reaction. The present proposal will study the mechanisms by which neuroinflammation could transition from a beneficial to a detrimental outcome in preclinical models of Alzheimer's disease (the most prevalent form of dementia), amyotrophic lateral sclerosis (the most common motor neuron disease), and septic encephalopathy (the leading cause of mortality in intensive care units), three diseases sharing a prominent inflammatory component. Moreover, it will aim to identify genetic factors marking the key steps of this transition, both in preclinical models and samples of patients suffering from the respective diseases, in order to find points of intervention for early diagnosis and development of better targeted and more efficient therapeutic strategies.
Program
Team Grant: Neuroinflammation
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
312947
Name
Tremblay Marie-Ève
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Federal Ministry of Education and Research (Germany); Israeli Ministry of Health; Fonds de recherche du Québec - Santé (FRQS); The French National Research Agency (France)
Instname2
Aging
Theme2
Biomedical
Prcname2
Special Cases
Projecttitle
Transition from acute to chronic neuroinflammation
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$104,235
Cihrequipment2
$0
Programname2
Team Grant: Neuroinflammation
Keyworddelim
Alzheimer'S Disease; Amyotrophic Lateral Sclerosis; Microglia; Neuroinflammation; Septic Encephalopathy
Abstract
Neuroinflammation is how the immune system of the brain fights against diseases. As a natural defense mechanism, this reaction may harbor beneficial effects, but under circumstances not yet well understood, it may also have detrimental consequences for the brain and even contribute to the progression of the disease that initially stimulated the immune reaction. The present proposal will study the mechanisms by which neuroinflammation could transition from a beneficial to a detrimental outcome in preclinical models of Alzheimer's disease (the most prevalent form of dementia), amyotrophic lateral sclerosis (the most common motor neuron disease), and septic encephalopathy (the leading cause of mortality in intensive care units), three diseases sharing a prominent inflammatory component. Moreover, it will aim to identify genetic factors marking the key steps of this transition, both in preclinical models and samples of patients suffering from the respective diseases, in order to find points of intervention for early diagnosis and development of better targeted and more efficient therapeutic strategies.
Competitiondate
201406
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tremblay, Marie-Ève
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Neurosc Mental Hlth &A~ $104,235~ $0~